The views and opinions expressed are those of the contributing authors and editors and do not necessarily represent the views of the ACC. More
Which should we measure after bypass?
When can this patient proceed to stress testing?
Dr. James Januzzi discusses troponin in patients with heart failure.
Are absolute changes in hs-cTnT better for differentiating ACS and non-ACS patients?
What diagnostic and prognostic utility does galectin-3 have for HF?
What is the incidence of cTnT elevation, and what is its clinical significance, in HF?
Meta-Analyses of the Association Between Cytochrome CYP2C19 Loss- and Gain-of-Function Polymorphisms and Cardiovascular Outcomes in Patients With Coronary Artery Disease Treated With Clopidogrel
ACC/AHA/ESC/WHF Universal Definition of Myocardial Infarction Classification System and the Risk of Cardiovascular Death: Observations From the TRITON-TIMI 38 Trial
High-Sensitivity C-Reactive Protein, Statin Therapy, and Risks of Atrial Fibrillation: An Exploratory Analysis of the JUPITER Trial
